- Home
- EXEL vs DDS Comparison
EXEL vs DDS Comparison
Compare EXEL & DDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- DDS
- Stock Information
- Founded
- EXEL 1994
- DDS 1938
- Country
- EXEL United States
- DDS United States
- Employees
- EXEL N/A
- DDS N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- DDS Department/Specialty Retail Stores
- Sector
- EXEL Health Care
- DDS Consumer Discretionary
- Exchange
- EXEL Nasdaq
- DDS Nasdaq
- Market Cap
- EXEL 10.4B
- DDS 9.2B
- IPO Year
- EXEL 2000
- DDS N/A
- Fundamental
- Price
- EXEL $37.88
- DDS N/A
- Analyst Decision
- EXEL Buy
- DDS Sell
- Analyst Count
- EXEL 22
- DDS 3
- Target Price
- EXEL $44.00
- DDS $394.33
- AVG Volume (30 Days)
- EXEL 2.4M
- DDS 110.1K
- Earning Date
- EXEL 10-28-2025
- DDS 11-13-2025
- Dividend Yield
- EXEL N/A
- DDS 4.36%
- EPS Growth
- EXEL 81.76
- DDS N/A
- EPS
- EXEL 2.08
- DDS 36.31
- Revenue
- EXEL $2,230,005,000.00
- DDS $6,585,750,000.00
- Revenue This Year
- EXEL $9.10
- DDS N/A
- Revenue Next Year
- EXEL $12.47
- DDS N/A
- P/E Ratio
- EXEL $18.54
- DDS $16.44
- Revenue Growth
- EXEL 10.73
- DDS N/A
- 52 Week Low
- EXEL $25.17
- DDS $282.24
- 52 Week High
- EXEL $49.62
- DDS $637.73
- Technical
- Relative Strength Index (RSI)
- EXEL 38.92
- DDS 46.47
- Support Level
- EXEL $38.35
- DDS $605.59
- Resistance Level
- EXEL $41.44
- DDS $623.94
- Average True Range (ATR)
- EXEL 0.97
- DDS 20.29
- MACD
- EXEL -0.26
- DDS -6.39
- Stochastic Oscillator
- EXEL 2.48
- DDS 9.93
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About DDS Dillard's Inc.
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.